Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 10, 2023

SELL
$1.05 - $1.63 $123,259 - $191,345
-117,390 Reduced 80.45%
28,534 $32,000
Q1 2023

May 12, 2023

BUY
$1.2 - $2.73 $28,878 - $65,697
24,065 Added 19.75%
145,924 $196,000
Q4 2022

Feb 10, 2023

BUY
$1.71 - $3.61 $136,721 - $288,633
79,954 Added 190.8%
121,859 $228,000
Q3 2022

Nov 01, 2022

BUY
$1.9 - $8.63 $79,619 - $361,640
41,905 New
41,905 $102,000
Q2 2022

Aug 09, 2022

BUY
$2.13 - $9.01 $572 - $2,423
269 Added 2.79%
9,925 $24,000
Q1 2022

May 12, 2022

BUY
$6.28 - $15.59 $540 - $1,340
86 Added 0.9%
9,656 $82,000
Q4 2021

Feb 14, 2022

BUY
$14.7 - $28.67 $3,219 - $6,278
219 Added 2.34%
9,570 $145,000
Q2 2021

Aug 11, 2021

SELL
$26.09 - $40.4 $47,535 - $73,608
-1,822 Reduced 16.31%
9,351 $315,000
Q1 2021

May 17, 2021

BUY
$33.06 - $56.93 $60,202 - $103,669
1,821 Added 19.47%
11,173 $425,000
Q4 2020

Feb 16, 2021

BUY
$39.09 - $57.4 $49,722 - $73,012
1,272 Added 15.74%
9,352 $390,000
Q3 2020

Nov 17, 2020

BUY
$28.43 - $44.67 $150,110 - $235,857
5,280 Added 188.57%
8,080 $350,000
Q3 2020

Nov 13, 2020

SELL
$28.43 - $44.67 $150,110 - $235,857
-5,280 Reduced 65.35%
2,800 $121,000
Q2 2020

Aug 17, 2020

BUY
$11.71 - $30.29 $29,356 - $75,937
2,507 Added 44.98%
8,080 $243,000
Q4 2019

Feb 11, 2020

BUY
$15.02 - $20.57 $83,706 - $114,636
5,573 New
5,573 $89,000
Q3 2019

Oct 25, 2019

SELL
$18.85 - $27.5 $216,963 - $316,525
-11,510 Closed
0 $0
Q2 2019

Jul 31, 2019

BUY
$17.37 - $26.27 $62,358 - $94,309
3,590 Added 45.33%
11,510 $0
Q4 2018

Feb 12, 2019

BUY
$9.26 - $16.38 $46,485 - $82,227
5,020 Added 173.1%
7,920 $84,000
Q3 2017

Nov 09, 2017

BUY
$8.89 - $10.4 $25,781 - $30,160
2,900
2,900 $26,000

Others Institutions Holding NVTA

About Invitae Corp


  • Ticker NVTA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 235,266,000
  • Description
  • Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...
More about NVTA
Track This Portfolio

Track Great West Life Assurance CO Portfolio

Follow Great West Life Assurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Great West Life Assurance CO , based on Form 13F filings with the SEC.

News

Stay updated on Great West Life Assurance CO with notifications on news.